Novartis oral multiple sclerosis drug meets main goal
Novartis’ oral multiple sclerosis drug meets its main goal in late-stage studies.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.